2026年3月20日,EyePoint公司已正式向美国马萨诸塞州米德尔塞克斯县高等法院递交诉状,对生物技术公司Ocular Therapeutix提起诉讼。此举标志着两家在眼科治疗领域具有重要影响力的企业之间法律纠纷的公开化。
2026年3月20日,EyePoint公司已正式向美国马萨诸塞州米德尔塞克斯县高等法院递交诉状,对生物技术公司Ocular Therapeutix提起诉讼。此举标志着两家在眼科治疗领域具有重要影响力的企业之间法律纠纷的公开化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.